A new method to reduce IOP
A new method to reduce IOP has worked out In the group of studies of the pathogenesis of glaucoma in the Glaucoma and Lens Pathology department of the Filatov. The method is based on instillations of the recombinant peptide. As a peptide, the use of endothelial monocyte-activating factor II (EMAP II), which is administered as single-handed to the eye in the form of instillations at a concentration of 3.9 μ g / kg. This is evidenced by the declarative patent for utility model No. 116465, from 05/25/2017 IPC (2017.01) A61K 39/00, A61P 27/00 "The method to reduce high intraocular pressure" authors: Irina Nikolaevna Mikhaytseva; Siroshtanenko Tatyana Ivanovna; Sagach Vadim Fedorovich;Dorofeeva Natalia Alexandrovna; Kornelyuk Alexander Ivanovich.
Contact person: Miheitseva I.N., Dr. Sc. Biol
Phone Number: +38 (048) 729 84 85